WaveMan
WaveMan · Form 4
Glover Stephen C. insider trades
> Search tickers & screens ⌘K
LIVE

Glover Stephen C. insider trades

Glover Stephen C. has filed 13 Form 4s with the SEC that we hold, for PDS Biotechnology Corp (PDSB) (Director), ZyVersa Therapeutics, Inc. (ZVSA) (Chief Executive Officer, Director), AMAM (Director) and AMAM (Director), among 5 companies in all. Across all of them we count 1 purchase worth $25.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 15,061 shares of PDS Biotechnology Corp worth $25.0K, dated 2025-02-28. The first filing on our record is dated 2022-06-29 and the latest 2026-06-03.

PDS Biotechnology Corp (PDSB)

Director · 6 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiledSource
2025-02-28P, purchase reported on Form 415,061$25.0K2025-03-03SEC

ZyVersa Therapeutics, Inc. (ZVSA)

Chief Executive Officer, Director · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

AMAM

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

AMAM

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Oncolytics Biotech INC (ONCY)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1304406) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms